AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.690

+0.0902.50%

Volume:1.57M

Turnover:5.83M

Market Cap:2.11B

PE:-26.36

High:3.790

Open:3.680

Low:3.630

Close:3.600

52wk High:5.420

52wk Low:0.225

Shares:572.19M

Float Shares:377.76M

Volume Ratio:0.57

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.140

EPS(LYR):-0.140

ROE:-44.49%

ROA:-27.64%

PB:32.87

PE(LYR):-26.36

Loading ...

Overview Company News Filings

How Expanded CT:VQ Roll-Out With UChicago Medicine Will Impact 4DMedical (ASX:4DX) Investors

Simply Wall St.

Assessing 4DMedical (ASX:4DX) Valuation After Expanded CT:VQ Partnership With University Of Chicago Medicine

Simply Wall St.

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Stocks Struggle

MT Newswires Live

4DMedical Says Underlying Software-As-A-Service Revenue Jumps 31% YOY In Fiscal 2026 H1, Shares Climb 6%

MT Newswires Live

4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%

MT Newswires Live

4DMedical (ASX:4DX) Is Down 11.0% After A$79m CT:VQ™ Funding Round Has The Bull Case Changed?

Simply Wall St.

Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%

MT Newswires Live

BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US

Assessing 4DMedical (ASX:4DX) Valuation After A$79.06 Million Follow On Equity Offering

Simply Wall St.

BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung Imaging

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and Increase Technology Dominance in Software-Based Lung Imaging

THOMSON REUTERS

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

ASX Biggest Losers

MT Newswires Live

4DMedical (ASX:4DX) Is Up 12.1% After A$150m Raise And Philips Deal Expansion Has The Bull Case Changed?

Simply Wall St.

Assessing 4DMedical’s Valuation After Its A$79.1m Follow On Equity Offering

Simply Wall St.

ASX Biggest Gainers

MT Newswires Live

BRIEF-4DMedical Completes A$150 MLN Institutional Placement At A$3.80 Per Share

4DMedical Raises AU$150 Million via Placement; Shares Down 4%

MT Newswires Live

BUZZ-Australia's 4DMedical falls on discounted placement

4DMedical Ltd - Completes a$150 Mln Institutional Placement at a$3.80 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/4DX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.69,"timestamp":1771989428543,"preClose":3.6,"halted":0,"volume":1569654,"delay":0,"changeRate":0.02499999999999996,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":572191242,"eps":-0.14,"marketStatus":"Trading","change":0.09,"latestTime":"02-25 14:17:12 AEDT","open":3.68,"high":3.79,"low":3.63,"amount":5832383,"amplitude":0.044444,"askPrice":3.7,"askSize":13940,"bidPrice":3.69,"bidSize":972,"shortable":3,"etf":0,"ttmEps":-0.14,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771995600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":3.6,"openAndCloseTimeList":[[1771974000000,1771995600000]],"volumeRatio":0.574593,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-27.64%","roe":"-44.49%","lyrEps":-0.14,"volumeRatio":0.574593,"shares":572191242,"dividePrice":0,"high":3.79,"amplitude":0.044444,"preClose":3.6,"low":3.63,"week52Low":0.225,"pbRate":"32.87","psRate":"360.71","week52High":5.42,"institutionHeld":0,"latestPrice":3.69,"committee":-0.869635,"eps":-0.14,"divideRate":0,"volume":1569654,"delay":0,"ttmEps":-0.14,"open":3.68,"prevYearClose":3.93,"prevWeekClose":3.88,"prevMonthClose":3.17,"prevQuarterClose":3.93,"fiveDayClose":3.97,"twentyDayClose":3.55,"sixtyDayClose":1.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609862590","title":"How Expanded CT:VQ Roll-Out With UChicago Medicine Will Impact 4DMedical (ASX:4DX) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2609862590","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609862590?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:15","pubTimestamp":1770380146,"startTime":"0","endTime":"0","summary":"In early February 2026, 4DMedical announced that its partnership with University of Chicago Medicine had been expanded to include commercial deployment of its CT:VQ lung imaging technology.\nThis move not only broadens real-world use of CT:VQ in a major academic hospital, but also underscores external confidence in 4DMedical’s commercial approach.\nWe’ll now examine how this expanded CT:VQ roll-out with University of Chicago Medicine shapes 4DMedical’s investment narrative and long-term...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-expanded-ctvq-roll-out-with-uchicago-medicine-will-impac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-expanded-ctvq-roll-out-with-uchicago-medicine-will-impac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4543","BK4587","BK4588","BK4023","ISBC","AI","BK4551","BK4528","BK4211","BK7094","4DX.AU","BK4585"],"gpt_icon":0},{"id":"2608367835","title":"Assessing 4DMedical (ASX:4DX) Valuation After Expanded CT:VQ Partnership With University Of Chicago Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2608367835","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608367835?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:22","pubTimestamp":1770200558,"startTime":"0","endTime":"0","summary":"Why 4DMedical Shares Are Back in Focus\n4DMedical (ASX:4DX) is back on investor radars after expanding its partnership with University of Chicago Medicine to include commercial deployment of its CT:VQ respiratory imaging technology.\nSee our latest analysis for 4DMedical.\nThe commercial CT:VQ rollout headlines a period where 4DMedical’s 90 day share price return of about 131% contrasts sharply with a 26% decline year to date, while its one year total shareholder return is very large at over...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-expanded-ctvq-par","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-expanded-ctvq-par","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2607396061","title":"ASX Midday Sector Update: Healthcare  Stocks Jump, Information Technology Stocks Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2607396061","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607396061?lang=en_us&edition=fundamental","pubTime":"2026-01-30 10:35","pubTimestamp":1769740529,"startTime":"0","endTime":"0","summary":"Shares of healthcare firms jumped nearly 2% at midday Friday, amid a five-month hike in oil prices on escalating supply concerns.4DMedical  said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year.On the flip side, the information technology sector fell by over 1%.Spark New Zealand  completed the sale of a 75% stake in its data center division to Pacific Equity Partners.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK7042","BK4585","BK4137","BK4581","XBI","XLV","III","LU0128526141.USD","LU0029874061.USD","BK4588","4DX.AU","SPK.AU","LABU","BK7094","BK4134"],"gpt_icon":0},{"id":"2607065842","title":"4DMedical Says Underlying Software-As-A-Service Revenue Jumps 31% YOY In Fiscal 2026 H1, Shares Climb 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607065842","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607065842?lang=en_us&edition=fundamental","pubTime":"2026-01-30 09:13","pubTimestamp":1769735628,"startTime":"0","endTime":"0","summary":"4DMedical  said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year, according to a Friday Australian bourse filing.It expanded its existing distribution agreement with Koninklijke Philips, under which Philips will distribute CT:VQ, the firm's computed tomography-based ventilation-perfusion imaging technology, to healthcare systems across the US and Canada on full commercial terms.The agreement includes a mechanism wherein Philips underwrites the minimum order commitment of around AU$15 million in customer orders over 2026 and 2027.Its shares jumped 6% in recent trading on Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2607050428","title":"4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607050428","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607050428?lang=en_us&edition=fundamental","pubTime":"2026-01-30 08:04","pubTimestamp":1769731492,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2606799784","title":"4DMedical (ASX:4DX) Is Down 11.0% After A$79m CT:VQ™ Funding Round Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606799784","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606799784?lang=en_us&edition=fundamental","pubTime":"2026-01-28 14:22","pubTimestamp":1769581322,"startTime":"0","endTime":"0","summary":"In mid-January 2026, 4DMedical Limited completed a follow-on equity offering of A$79.06 million, issuing 20,806,185 new ordinary shares at A$3.80 each, after holding a special call to explain the capital raise.\nThe company highlighted that the funds from this institutional placement will support the U.S. rollout of its CT:VQ™ lung imaging product, expand deployments in leading hospitals, and further its software-based respiratory imaging research efforts.\nWe will now examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-down-110-after-a79m-ctvq-funding-round-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-down-110-after-a79m-ctvq-funding-round-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","BK4587","BK4585","BK4543","BK4528","BK4588","4DX.AU","BK7094","AI","BK4551"],"gpt_icon":0},{"id":"2606275051","title":"Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606275051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606275051?lang=en_us&edition=fundamental","pubTime":"2026-01-27 10:15","pubTimestamp":1769480153,"startTime":"0","endTime":"0","summary":"Cyclopharm  confirmed that its insurer accepted indemnity regarding proceedings brought by 4DMedical  in the Supreme Court of Victoria against the firm and the insurer assumed conduct of the defense on Cyclopharm's behalf, according to a Tuesday Australian bourse filing.4DMedical sued the firm over allegedly misleading comments made during a March webinar, claiming the comment about its capital raising statements was false and misleading, and alleging that it caused damage to the company.Its shares jumped 11% in recent trading on Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","VCCTF","BK4095","4DX.AU","BK7094","CYC.AU"],"gpt_icon":1},{"id":"2606426278","title":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2606426278","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606426278?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:14","pubTimestamp":1769476465,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US** Shares of Cyclopharm CYC.AX advance as much as 15.34% to A$1.015, their biggest intraday pct gain December 1, 2025** The ra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nL6N3YS02L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","CYC.AU","4DX.AU","BK7007"],"gpt_icon":0},{"id":"2606820372","title":"Assessing 4DMedical (ASX:4DX) Valuation After A$79.06 Million Follow On Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2606820372","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606820372?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:43","pubTimestamp":1769474602,"startTime":"0","endTime":"0","summary":"Follow on equity offer puts 4DMedical in focus\n4DMedical (ASX:4DX) has drawn fresh investor attention after completing a follow on equity offering, raising A$79.06 million through the issue of more than 20,806,000 new ordinary shares at A$3.80 each.\nSee our latest analysis for 4DMedical.\nDespite the capital raise pricing the new shares at A$3.80, 4DMedical’s latest share price of A$4.05 sits above that level. The 90 day share price return is above 100% and the 1 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-a7906-million-fol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-a7906-million-fol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4215","BK7094","4DX.AU","BK4588","EQR"],"gpt_icon":0},{"id":"2606422466","title":"BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2606422466","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606422466?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:53","pubTimestamp":1769468025,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung ImagingJan 26 (Reuters) - 4DMedical Ltd 4DX.AX:4DMEDICAL SECURES U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2606214492","title":"4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and Increase Technology Dominance in Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2606214492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606214492?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:28","pubTimestamp":1769466501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2604192537","title":"4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2604192537","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604192537?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:00","pubTimestamp":1768906800,"startTime":"0","endTime":"0","summary":"Funding will scale hospital deployments for groundbreaking CT:VQ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and moreLOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million  in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading \"CT:VQ\" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.Backed by new institutional funding, 4DMedical is advancing its respiratory imaging technology and expanding the U.S. rollout of its FDA-cleared CT:VQ software.Following the raise, 4DMedical reported a pro forma cash position exceeding US$130+ million , which will support the company's U.S. expansion strategy and growing installed base.Built to integrate into clini","market":"other","thumbnail":"https://mma.prnewswire.com/media/2865006/4DMedical_Respiratory_Imaging.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2865006/4DMedical_Respiratory_Imaging.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/4dmedical-secures-us100-million-funding-to-accelerate-us-expansion-and-increase-technology-dominance-in-software-based-lung-imaging-302665063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAQC","4DX.AU","BK7094"],"gpt_icon":0},{"id":"2604163777","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2604163777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604163777?lang=en_us&edition=fundamental","pubTime":"2026-01-20 11:51","pubTimestamp":1768881077,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Tuesday.ARB : -12%, AU$28.544DMedical : -9%, AU$4.39Dateline Resources : -7%, AU$0.36Lynas Rare Earths : -7%, AU$15.15Clarity Pharmaceuticals : -6%, AU$3.06Perenti : -6%, AU$2.82Vulcan Energy : -6%, AU$4.04Austal : -6%, AU$8.06Orora : -6%, AU$2.13Pmet Resources : -5%, AU$0.65","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","LYC.AU","ARB.AU","BK7095","CU6.AU","BK7504","BK7115","BK7051","PRN.AU","VUL.AU","BK7507","ORA.AU","PMT.AU","BK7096","BK7094","BK7053","ASB.AU","4DX.AU","DTR.AU"],"gpt_icon":0},{"id":"2604113287","title":"4DMedical (ASX:4DX) Is Up 12.1% After A$150m Raise And Philips Deal Expansion Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113287","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113287?lang=en_us&edition=fundamental","pubTime":"2026-01-19 19:11","pubTimestamp":1768821062,"startTime":"0","endTime":"0","summary":"4DMedical Limited recently completed a follow-on equity offering of A$79.06 million at A$3.80 per share, as part of a broader A$150 million capital raise to support commercialization of its CT:VQ lung imaging technology following FDA clearance.\nThe expanded distribution agreement with Philips, including a minimum US$10 million order commitment for 2026–2027 and growing use of CT:VQ in leading U.S. medical centers, points to a more intensive push into the North American market.\nNext, we’ll...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-121-after-a150m-raise-and-philips-dea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-121-after-a150m-raise-and-philips-dea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2603992103","title":"Assessing 4DMedical’s Valuation After Its A$79.1m Follow On Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603992103","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603992103?lang=en_us&edition=fundamental","pubTime":"2026-01-16 21:21","pubTimestamp":1768569711,"startTime":"0","endTime":"0","summary":"Why 4DMedical’s New Capital Raise Matters for Investors\n4DMedical (ASX:4DX) has completed a follow on equity offering, raising about A$79.1 million by issuing 20,806,185 ordinary shares at A$3.80 each, which represents a A$0.19 discount per share.\nSee our latest analysis for 4DMedical.\n4DMedical’s latest capital raise comes after a sharp shift in sentiment, with a 30 day share price return of 79.51% and a 90 day share price return of 189.46%. Over the longer term, total shareholder return has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-its-a791m-follow-on-equ","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-its-a791m-follow-on-equ","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4215","EQR","BK4585","BK7094","4DX.AU","BK4588"],"gpt_icon":0},{"id":"2603958053","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603958053","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603958053?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:13","pubTimestamp":1768529589,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Friday.Energy Resources of Australia : +20%, AU$0.003DroneShield : +8%, AU$4.41Catalyst Metals : +8%, AU$8.45Deep Yellow : +7%, AU$2.14Capstone Copper : +7%, AU$15.684DMedical : +7%, AU$4.84Minerals 260 : +7%, AU$0.47Paladin Energy : +5% AU$11.23Kingsgate Consolidated : +5%, AU$6.48HUB24 : +5%, AU$97.91","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7115","DYL.AU","CSC.AU","ERA.AU","HUB.AU","BK7083","MI6.AU","BK7054","BK7104","BK7110","BK7094","BK7509","BK7095","KCN.AU","PDN.AU","CYL.AU","4DX.AU","DRO.AU"],"gpt_icon":1},{"id":"2603201936","title":"BRIEF-4DMedical Completes A$150 MLN Institutional Placement At A$3.80 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2603201936","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603201936?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:17","pubTimestamp":1768450674,"startTime":"0","endTime":"0","summary":"BRIEF-4DMedical Completes A$150 MLN Institutional Placement At A$3.80 Per ShareJan 15 (Reuters) - 4DMedical Ltd 4DX.AX:COMPLETES A$150 MILLION INSTITUTIONAL PLACEMENT AT A$3.80 PER SHAREFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF1W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2603629641","title":"4DMedical Raises AU$150 Million via Placement; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603629641","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603629641?lang=en_us&edition=fundamental","pubTime":"2026-01-15 09:34","pubTimestamp":1768440887,"startTime":"0","endTime":"0","summary":"4DMedical  received firm commitments to raise AU$150 million through a placement of 20.8 million shares at AU$3.80 apiece, according to a Thursday filing with the Australian bourse.The capital raise involves a AU$79.1 million placement of new shares and a AU$70.9 million block trade of existing shares on issue, the filing said.Proceeds will be mainly used to advance the commercialization of the company's CT:VQ software technology product in the US, per the filing.Shares fell 4% in midday trade on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2603862820","title":"BUZZ-Australia's 4DMedical falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603862820","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603862820?lang=en_us&edition=fundamental","pubTime":"2026-01-15 07:45","pubTimestamp":1768434307,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's 4DMedical falls on discounted placement** Shares of 4DMedical 4DX.AX fall as much as 9.1% to A$3.900, hitting their lowest level since Dec. 31** Stock logs its biggest intraday pct loss since Jan. 5** Respiratory imaging tech firm completes A$150 million   placement at issue price of A$3.80 apiece** Co says issue price at 11.4% discount to stock's last close** Stock has risen more than 5% so far this year after gaining over eight-fold in value in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL4N3YF25Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2603640449","title":"4DMedical Ltd - Completes a$150 Mln Institutional Placement at a$3.80 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2603640449","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603640449?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:56","pubTimestamp":1768431405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}]}}